Tg Therapeutics (TGTX) EBT: 2016-2025
Historic EBT for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $25.9 million.
- Tg Therapeutics' EBT rose 507.05% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.8 million, marking a year-over-year increase of 731.98%. This contributed to the annual value of $25.6 million for FY2024, which is 95.94% up from last year.
- As of Q3 2025, Tg Therapeutics' EBT stood at $25.9 million, which was down 16.21% from $30.9 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' EBT ranged from a high of $113.9 million in Q3 2023 and a low of -$94.0 million during Q4 2021.
- For the 3-year period, Tg Therapeutics' EBT averaged around $9.2 million, with its median value being $5.5 million (2025).
- As far as peak fluctuations go, Tg Therapeutics' EBT plummeted by 96.25% in 2024, and later spiked by 507.05% in 2025.
- Tg Therapeutics' EBT (Quarterly) stood at -$94.0 million in 2021, then increased by 14.49% to -$80.4 million in 2022, then skyrocketed by 82.55% to -$14.0 million in 2023, then skyrocketed by 281.47% to $25.5 million in 2024, then soared by 507.05% to $25.9 million in 2025.
- Its EBT was $25.9 million in Q3 2025, compared to $30.9 million in Q2 2025 and $5.5 million in Q1 2025.